Literature DB >> 28040478

Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells.

Vashendriya V V Hira1, Urška Verbovšek2, Barbara Breznik3, Matic Srdič4, Marko Novinec4, Hala Kakar5, Jill Wormer5, Britt Van der Swaan5, Brigita Lenarčič4, Luiz Juliano6, Shwetal Mehta7, Cornelis J F Van Noorden5, Tamara T Lah8.   

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor with poor patient survival that is at least partly caused by malignant and therapy-resistant glioma stem-like cells (GSLCs) that are protected in GSLC niches. Previously, we have shown that the chemo-attractant stromal-derived factor-1α (SDF-1α), its C-X-C receptor type 4 (CXCR4) and the cysteine protease cathepsin K (CatK) are localized in GSLC niches in glioblastoma. Here, we investigated whether SDF-1α is a niche factor that through its interactions with CXCR4 and/or its second receptor CXCR7 on GSLCs facilitates their homing to niches. Furthermore, we aimed to prove that SDF-1α cleavage by CatK inactivates SDF-1α and inhibits the invasion of GSLCs. We performed mass spectrometric analysis of cleavage products of SDF-1α after proteolysis by CatK. We demonstrated that CatK cleaves SDF-1α at 3 sites in the N-terminus, which is the region of SDF-1α that binds to its receptors. Confocal imaging of human GBM tissue sections confirmed co-localization of SDF-1α and CatK in GSLC niches. In accordance, 2D and 3D invasion experiments using CXCR4/CXCR7-expressing GSLCs and GBM cells showed that SDF-1α had chemotactic activity whereas CatK cleavage products of SDF-1α did not. Besides, CXCR4 inhibitor plerixafor inhibited invasion of CXCR4/CXCR7-expressing GSLCs. In conclusion, CatK can cleave and inactivate SDF-1α. This implies that CatK activity facilitates migration of GSLCs out of niches. We propose that activation of CatK may be a promising strategy to prevent homing of GSLCs in niches and thus render these cells sensitive to chemotherapy and radiation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cathepsin K; Glioma stem-like cells; Niche; Stromal-derived factor-1α

Mesh:

Substances:

Year:  2016        PMID: 28040478     DOI: 10.1016/j.bbamcr.2016.12.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  19 in total

1.  Kinins in Glioblastoma Microenvironment.

Authors:  Mona N Oliveira; Barbara Breznik; Micheli M Pillat; Ricardo L Pereira; Henning Ulrich; Tamara T Lah
Journal:  Cancer Microenviron       Date:  2019-08-16

2.  Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies.

Authors:  Vashendriya V V Hira; Barbara Breznik; Miloš Vittori; Annique Loncq de Jong; Jernej Mlakar; Roelof-Jan Oostra; Mohammed Khurshed; Remco J Molenaar; Tamara Lah; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2019-09-30       Impact factor: 2.479

3.  Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.

Authors:  Vashendriya V V Hira; Jill R Wormer; Hala Kakar; Barbara Breznik; Britt van der Swaan; Renske Hulsbos; Wikky Tigchelaar; Zbynek Tonar; Mohammed Khurshed; Remco J Molenaar; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2018-01-03       Impact factor: 2.479

Review 4.  Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.

Authors:  Vashendriya V V Hira; Diana A Aderetti; Cornelis J F van Noorden
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

5.  Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.

Authors:  Barbara Breznik; Meng-Wei Ko; Christopher Tse; Po-Chun Chen; Emanuela Senjor; Bernarda Majc; Anamarija Habič; Nicolas Angelillis; Metka Novak; Vera Župunski; Jernej Mlakar; David Nathanson; Anahid Jewett
Journal:  Commun Biol       Date:  2022-05-10

Review 6.  Insights in the immunobiology of glioblastoma.

Authors:  Dimitrios Strepkos; Mariam Markouli; Alexia Klonou; Christina Piperi; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2019-10-24       Impact factor: 4.599

Review 7.  An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5.

Authors:  Tamara Lah Turnšek; Xuanmao Jiao; Metka Novak; Sriharsha Jammula; Gina Cicero; Anthony W Ashton; David Joyce; Richard G Pestell
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

8.  The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma.

Authors:  Jintao Chen; Sifeng Mao; Haifang Li; Mingcheng Zheng; Linglu Yi; Jin-Ming Lin; Zhi-Xiong Lin
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

Review 9.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

10.  CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.

Authors:  Metka Novak; Miha Koprivnikar Krajnc; Barbara Hrastar; Barbara Breznik; Bernarda Majc; Mateja Mlinar; Ana Rotter; Andrej Porčnik; Jernej Mlakar; Katja Stare; Richard G Pestell; Tamara Lah Turnšek
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.